Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Reed MC, Moscucci M, Smith DE, Share D, LaLonde T, Mahmood SA, D'Haem C, McNamara R, Greenbaum A, Gurm HS.

J Invasive Cardiol. 2010 Oct;22(10):467-72.

PMID:
20944185
[PubMed - indexed for MEDLINE]
Free Article
2.

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ; SPIRIT IV Investigators.

N Engl J Med. 2010 May 6;362(18):1663-74. doi: 10.1056/NEJMoa0910496.

PMID:
20445180
[PubMed - indexed for MEDLINE]
Free Article
3.

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators.

N Engl J Med. 2009 May 21;360(21):2176-90. doi: 10.1056/NEJMoa0901316. Epub 2009 Mar 30.

PMID:
19332455
[PubMed - indexed for MEDLINE]
Free Article
4.

Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database.

Moscucci M, Share D, Smith D, O'Donnell MJ, Riba A, McNamara R, Lalonde T, Defranco AC, Patel K, Kline Rogers E, D'Haem C, Karve M, Eagle KA.

J Am Coll Cardiol. 2005 Aug 16;46(4):625-32.

PMID:
16098426
[PubMed - indexed for MEDLINE]
Free Article
5.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

PMID:
14610160
[PubMed - indexed for MEDLINE]
Free Article
6.

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial.

Weaver WD, Reisman MA, Griffin JJ, Buller CE, Leimgruber PP, Henry T, D'Haem C, Clark VL, Martin JS, Cohen DJ, Neil N, Every NR.

Lancet. 2000 Jun 24;355(9222):2199-203.

PMID:
10881893
[PubMed - indexed for MEDLINE]
7.

Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study.

Makkar R, Goff B, Eigler N, Sebastian M, Fischell T, Barr L, D'Haem C, Shah PK, Effron MB, Litvack F.

Catheter Cardiovasc Interv. 1999 Dec;48(4):430-4.

PMID:
10559827
[PubMed - indexed for MEDLINE]
8.

Acute interventions for myocardial reperfusion.

Brown M, D'Haem C, Berkompas D, Cohn JM.

Emerg Med Clin North Am. 1998 Aug;16(3):565-81, viii. Review.

PMID:
9739775
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk